SCHEMBL8447326

SCHEMBL8447326

ICCOCN1C=CC=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9596938 0.78
SCHEMBL5460292 0.66
SCHEMBL23290132 0.66
SCHEMBL2230204 0.66
SCHEMBL3064631 0.65
SCHEMBL11369100 0.63
SCHEMBL28253540 0.63
SCHEMBL8688530 0.62
SCHEMBL30221912 0.62
SCHEMBL8447327 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0766691-B1 HYDROXYALKYLAMMONIUM-PYRIMIDINES OR PURINES AND NUCLEOSIDE DERIVATIVES, USEFUL AS INHIBITORS OF INFLAMMATORY CYTOKINES MACRONEX INC (US) 1999-11-10 EP disclosed
US-5679684-A INTIINFLAMMATORY AGENTS, ANTIARTHRITIS AGENTS, NERVOUS SYSTEM DISORDERS, AIDS MACRONEX, INC. (US) 1997-10-21 US disclosed
US-5550132-A TREATING SEPTIC SHOCK, CACHEXIA, RHEUMATOID ARTHRITIS, INFLAMMATORY BOWEL DISEASE, MULTIPLE SCLEROSIS, AIDS UNIVERSITY OF NORTH CAROLINA (US) 1996-08-27 US disclosed